ILEX Oncology, Inc. is a product-driven oncology-focused pharmaceutical company that develops and commercializes a portfolio of novel treatments for both early and late stage cancers. The Company is leveraging its core competencies in clinical drug development to identify, develop and commercialize its proprietary product candidates. 
 

4545 Horizon Hill Blvd.
San Antonio, TX 78229
Phone: (210) 949-8200
Fax: (210) 949-8415